Results 241 to 250 of about 259,973 (348)

Successful pregnancy in a patient with active Crohn's disease, chronic intestinal failure, and long‐term parenteral nutrition receiving upadacitinib: A case report

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Data on pregnancy in patients with Crohn's disease receiving Janus kinase (JAK) inhibitors, with concomitant short bowel syndrome and chronic intestinal failure requiring long‐term parenteral support, are extremely limited. We report the case of a patient with refractory Crohn's disease, short bowel syndrome–associated chronic intestinal ...
Diana Coman   +2 more
wiley   +1 more source

Specific phenotypes may drive an increased incidence of pediatric inflammatory bowel disease in South‐Eastern Norway

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric inflammatory bowel disease (PIBD) incidence has increased in recent decades but may be stabilizing, prompting exploration of incidence changes, disease distribution, and severity. Methods From 2017 to 2019, patients under 18 years with PIBD symptoms were recruited from nine hospitals in South‐Eastern Norway for ...
Svend Andersen   +12 more
wiley   +1 more source

Ulcerative colitis and colorectal cancer: Pathogenic insights and precision strategies for prevention and treatment. [PDF]

open access: yesWorld J Gastrointest Oncol
Catalano M   +9 more
europepmc   +1 more source

Prognosis of pediatric‐onset inflammatory bowel disease associated with primary sclerosing cholangitis: A population‐based study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives To assess whether the prognosis of pediatric‐onset inflammatory bowel disease (IBD) is influenced by its association with primary sclerosing cholangitis (PSC) considering medical treatment, bowel resection, risk of cancer, and mortality. Methods A retrospective population‐based study was conducted using data from the EPIMAD Registry,
Marie‐Laura Godet   +10 more
wiley   +1 more source

A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for pediatric use

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) presents before age 20 years in ~25% of patients. Regulatory approvals of IBD medications for pediatric use are often delayed. Nevertheless, many pediatric patients receive medication not approved for pediatric use.
Courtney Rusch   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy